Armenia vs Colombia: Cause of death, by non-communicable diseases, ages 0-4
Armenia
34.5%
in 2021
Colombia
35.2%
in 2021
Armenia rank
76th
Colombia rank
73rd
Cause of death, by non-communicable diseases, ages 0-4 over time
- Armenia
- Colombia
How they compare
Colombia currently reports 35.2% against 34.5% in Armenia, a difference of 0.7%.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was Colombia ahead.
Armenia ranks 76th and Colombia ranks 73rd of 185 countries.
Across the 3 decades both report, Armenia averaged higher in 2 and Colombia in 1.
Head to head by decade
| Decade | Armenia | Colombia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 22.0% | 22.7% | 0.7% | Colombia |
| 2010s | 35.0% | 34.5% | 0.5% | Armenia |
| 2020s | 35.5% | 34.9% | 0.6% | Armenia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 0-4, Armenia or Colombia?
- Colombia, at 35.2% against 34.5% in Armenia as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 0-4 between Armenia and Colombia?
- 0.7%, with Colombia ahead.
- How many years of comparable data are there for Armenia and Colombia?
- 6 years are reported by both, from 2000 to 2021.
- How do Armenia and Colombia rank globally for cause of death, by non-communicable diseases, ages 0-4?
- Armenia ranks 76th and Colombia ranks 73rd of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 0-4 (% of total deaths ages 0-4). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 0-4 due to non-communicable diseases divided by number of all deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.